Indications
Apixaban is a factor Xa inhibitor. It is used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also used for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. And it is used for the treatment of DVT and PE, and to reduce the risk of recurrent DVT and PE after initial therapy.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Apixaban works by inhibiting coagulation, so it stops blood clots from forming. Because it inhibits FXa, apixaban also lengthens clotting tests such as prothrombin time (PT), INR and activated partial thromboplastin time (aPTT). At the expected therapeutic dose, though, the changes seen in these tests are small and vary a great deal from one person to another. So they are not useful for monitoring the anticoagulation effect of apixaban.
Pregnancy & Breastfeeding
Pregnancy: There are no adequate and well-controlled studies of Apixaban in pregnant women. Treatment is likely to increase the risk of hemorrhage during pregnancy and delivery. Apixaban should be used in pregnancy only if the potential benefit outweighs the potential risk to the mother and the fetus.
Labor and Delivery: The safety and effectiveness of Apixaban during labor and delivery have not been studied in clinical trials. Think about the risk of bleeding and the risk of stroke when using Apixaban in this situation.
Nursing Mothers: It is unknown whether Apixaban or its metabolites pass into human milk. Women should be told either to stop breastfeeding or to stop Apixaban therapy, taking into account how important the medicine is to the mother.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.